文献速递流行病学与生物统计基础与转化研究

分层交互作用的Lasso估计用于分析治疗效应异质性

Lasso estimation of hierarchical interactions for analyzing heterogeneity of treatment effect.
PubMed 文献 · Stat Med · 2021-07-08

针对个体对治疗反应不同的问题,提出一种遵循分层条件的治疗-协变量交互作用建模框架,构建单步l1范数惩罚程序,并开发两种参数化方案的约束Lasso方法。模拟研究表明该方法模型更简约且优于非结构化Lasso,并在N=2569的充血性心力衰竭随机临床试验数据中得到验证。

要点

  • 分层约束Lasso可识别治疗-协变量交互作用并保持分层结构。
  • 模拟研究中该方法比非结构化Lasso更简约且交互作用识别更准确。
  • 适用于临床试验二次分析以分析治疗效应异质性并识别预测生物标志物。

核心结论

  • 所提出的约束Lasso方法能更简约且准确地识别非零治疗-协变量交互作用。

研究设计与样本

  • 方法学研究:构建单步l1范数惩罚程序,开发两种参数化方案的约束Lasso,并用谱投影梯度法求解。
  • 通过模拟研究比较该方法与非结构化Lasso,包括违反分层条件的错误指定模型场景。
  • 应用于一项充血性心力衰竭药物的大型随机临床试验数据(N = 2569)。

主要发现

  • 模拟研究中,所提方法产生更简约的模型,在正确识别非零治疗-协变量交互作用方面优于非结构化Lasso。
  • 在N = 2569的充血性心力衰竭随机临床试验数据应用中,所提方法的优越性能得到进一步证实。

关键数值与推荐

  • 交互项仅在协变量或协变量与治疗两者主效应非零时才纳入模型(分层条件)。

临床怎么用

  • 可用于临床试验二次分析,分析治疗效应异质性并识别预测生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Individuals differ in how they respond to a given treatment. In an effort to predict the treatment response and analyze the heterogeneity of treatment effect, we propose a general modeling framework by identifying treatment-covariate interactions honoring a hierarchical condition. We construct a single-step l1 norm penalty procedure that maintains the hierarchical structure of interactions in the sense that a treatment-covariate interaction term is included in the model only when either the covariate or both the covariate and treatment have nonzero main effects. We developed a constrained Lasso approach with two parameterization schemes that enforce the hierarchical interaction restriction differently. We solved the resulting constrained optimization problem using a spectral projected gradient method. We compared our methods to the unstructured Lasso using simulation studies including a scenario that violates the hierarchical condition (misspecified model). The simulations showed that our methods yielded more parsimonious models and outperformed the unstructured Lasso for correctly identifying nonzero treatment-covariate interactions. The superior performance of our methods are also corroborated by an application to a large randomized clinical trial data investigating a drug for treating congestive heart failure (N = 2569). Our methods provide a well-suited approach for doing secondary analysis in clinical trials to analyze heterogeneous treatment effects and to identify predictive biomarkers.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Du Y, Chen H, Varadhan R, et al. Lasso estimation of hierarchical interactions for analyzing heterogeneity of treatment effect. Stat Med. 2021. PMID: 34240443. doi:10.1002/sim.9132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。